Pediatric obesity: Eventual development in adolescents with obesity is likely, following the pathway established by semaglutide (approved for adolescent obesity) and tirzepatide
A key finding was that the magnitude of semaglutides effects on several drinking outcomes appeared potentially greater than is often seen in similar studies with existing AUD medications, even though semaglutide was only administered at the lowest clinical doses
Article Summary Lipotropic injections release fat, target fatty deposits, and enhance metabolism with amino acids like methionine and choline, often combined with B-12 for energy
But in a context where coverage of GLP-1s is not required, (although in a recent column it was proposed that anti-obesity medications should be considered preventive by the US Preventive Services Task Force) an insurer might fear adverse selection if they covered the medications while their competitors did not
acknowledges support from the NIH (T32GM133332)
What does it mean if my reconstituted Melanotan-1 solution looks cloudy
